AGREEMENT AND PLAN OF MERGER by and among SCICLONE PHARMACEUTICALS, INC., SILVER BIOTECH INVESTMENT LIMITED, and SILVER DELAWARE INVESTMENT LIMITED Dated June 7, 2017Merger Agreement • June 8th, 2017 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into on June 7, 2017, by and among SciClone Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Silver Biotech Investment Limited, a company organized under the laws of the Cayman Islands (“Holdco”), and Silver Delaware Investment Limited, a Delaware corporation and wholly-owned subsidiary of Holdco (“Merger Sub”).
